Details of the Drug Therapeutic Target (DTT)

General Information of Drug Therapeutic Target (DTT) (ID: TT1HM0R)

DTT Name Kappa myeloma antigen (KMA)
Gene Name KMA
DTT Type
Clinical trial target
 [1]
BioChemical Class
Kappa myeloma antigen
UniProt ID
NOUNIPROTAC
TTD ID
T60628

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DTT
1 Clinical Trial Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
MDX-1097 DMCK8SX Haematological malignancy 2B33.Y Phase 2 [1]
------------------------------------------------------------------------------------

References

1 MDX-1097 induces antibody-dependent cellular cytotoxicity against kappa multiple myeloma cells and its activity is augmented by lenalidomide. Br J Haematol. 2015 May;169(3):333-43.